Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 57.79 M69.06 M73.7 M85.44 M 286 M Research & development ———— — Operating income -27.43 M22.18 M1.96 M32.15 M 28.87 M Non-Operating Income, Total 10.07 M-7.22 M-15.26 M1.52 M -10.88 M Interest expense, net of interest capitalized 5.59 M6.21 M4.83 M4.45 M 21.09 M Non-Operating Income, excl. Interest Expenses -10.6 M-11.92 M-8.94 M-7.77 M -39.23 M Unusual income/expense 15.09 M-1.51 M-11.15 M4.84 M 7.26 M Pretax income -17.35 M14.96 M-13.29 M33.67 M 17.98 M Equity in earnings ———— — Taxes -8.55 M6.72 M6.69 M5.37 M 10.22 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -8.8 M8.24 M-19.98 M28.3 M 7.76 M Discontinued operations ———— — Net income -8.8 M8.24 M-19.98 M28.3 M 7.76 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -8.81 M8.23 M-19.98 M28.3 M 7.74 M Basic earnings per share (Basic EPS) -0.370.34-0.831.18 0.32 Diluted earnings per share (Diluted EPS) -0.370.34-0.831.18 0.32 Average basic shares outstanding 24.12 M24.16 M24.17 M24.15 M — Diluted shares outstanding 24.12 M24.22 M24.17 M24.25 M — EBITDA -26.61 M22.97 M2.75 M31.69 M 30.8 M EBIT -27.43 M22.18 M1.96 M30.91 M 27.62 M Cost of revenue 8.28 M311.39 M354.5 M159.53 M 833.7 M Other cost of goods sold 8.28 M311.39 M354.5 M159.53 M 833.7 M Depreciation & amortization (cash flow) 811 K790 K790 K788 K 3.18 M